You are here
Global Coronary (Drug Eluting, Bare Metal Coronary, & Bioabsorbable) Stent Market 2019-2024
DUBLIN, April 3, 2019 /PRNewswire/ -- The "Coronary Stent Market- Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.
The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.
The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus the burden of CAD has increased and has boosted the usage of coronary stents, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.
There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.
Scope of the Report
As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.
Key Market Trends
Drug-eluting Stent is the Largest Segment by Product Type that is Expected to Grow during the Forecast Period
The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.
North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period
North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the ageing population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.
The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Market Dynamics
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
4.2.2 Rising of the Geriatric Population
4.2.3 Technological Advancements in Coronary Stents
4.3 Market Restraints
4.3.1 High Product Recalls
4.3.2 Stringent Approval Process for Stents
4.4 Porter's Five Forces Analysis
5 Market Segmentation
5.1 By Product Type
5.1.1 Drug Eluting Stent
5.1.2 Bare Metal Coronary Stent
5.1.3 Bioabsorbable Stent
5.2 By Biomaterial
5.2.1 Metallic Biomaterial
5.2.2 Polymeric Biomaterial
5.2.3 Natural Biomaterial
5.3 By End User
5.3.2 Ambulatory Surgical Centre
6 Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Medical Inc.
6.1.3 Biosensors International Group, Ltd.
6.1.4 BIOTRONIK SE & Co. KG
6.1.5 Boston Scientific Corporation
6.1.6 IRIDEX Corporation
6.1.7 Medtronic PLC
6.1.8 Terumo Corporation
6.1.9 Translumina GmbH
7 Market Opportunities and Future Trends
For more information about this report visit
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets